Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/embqCfbwocfDhdbFFwoA

March 1, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
 
  • Canada allots funds to support commercial isotope production
    The Canadian government has committed $24.3 million in support of three research facilities that will work on cyclotron and linear accelerator technologies for commercial-scale isotope production. The move is part of a push to produce an adequate supply of isotopes without using highly enriched uranium by 2016, when the isotope-producing reactor at Chalk River, Ontario, will be shut down. Natural Resources Minister Joe Oliver said the government is seeking a private partner for the Chalk River facility that will handle operations while the government retains ownership. Reuters (2/28) , Bloomberg Businessweek (2/28) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Every patient is UNIQUE.
So why should they all receive the same PET dose? The MEDRAD™ Intego™ PET Infusion System makes personalization practical. Clinicians can administer an accurate, personalized dose for each patient from a simple touch screen. To see how the MEDRAD™ Intego™ is enabling better patient care, click here.
  Clinical News & Research 
  • PET findings offer clues on psychogenic diseases
    Findings on PET scans showed abnormalities in the brain function of patients with psychogenic diseases, previously referred to as "hysterical" illness because patients report severe symptoms without clear physical manifestation. Researchers from the University of Cambridge assessed people with either psychogenic or organic dystonia, characterized by disabling muscle contractions in the leg. The researchers observed brain abnormalities when patients were instructed to place their problem legs in various positions. "Even more striking was that the differences were there all the time, whether the patients were resting or trying to move," said lead researcher James Rowe. Toronto Sun/QMI Agency (2/26) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • Digirad announces relocation, restructuring plans
    Digirad has announced it plans to relocate from Poway, Calif., to Atlanta. The move is in part an effort to cut costs, said Jeffry Keyes, Digirad's chief financial officer. The company also said CEO Todd Clyde will be replaced in six months by Matthew Molchan, who leads the company's Digital Imaging Services unit. The company is looking to broaden its Digirad Imaging Solutions business while reducing its diagnostic imaging camera operations. San Diego Union-Tribune (2/28) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Institute to explore, advance pediatric oncology
    Phoenix Children's Hospital is working with the University of Arizona College of Medicine and Translational Genomics Research Institute to advance the field of pediatric oncology. The partnership will create the Ronald A. Matricaria Institute of Molecular Medicine, which will employ pediatric specialists in oncology and genomics and use advanced imaging technologies such as PET/CT to advance research and conduct clinical trials to explore the underlying genetic and molecular mechanisms of pediatric cancer. Officials say the hospital's use of Image Gently protocols and advanced technology has allowed it to minimize radiation dose and limit use of sedation for imaging. HealthImaging.com (2/28) LinkedInFacebookTwitterEmail this Story
  International Developments 
  Health Policy 
  • Public health, medical research to suffer from sequestration
    Sequestration will have a major impact on public health and medical research, both of which have been restricted by years of underfunding and cuts. "These cuts are going to have a real impact," Washington state Health Secretary Mary Selecky said. "In the next six to eight weeks, we're going to have to say we're closed on Fridays or we can't provide this or that service anymore." Researchers who depend on NIH grants have also expressed concern that their work will have to be scaled back. Los Angeles Times (tiered subscription model) (2/27) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • EHR incentive payments reach $11.78B
    CMS announced it has released $11.78 billion in Medicaid, Medicare and Medicare Advantage EHR incentives from 2011 through January of this year. The agency said almost $7.9 billion went to hospitals, while eligible doctors and other health care professionals received $3.7 billion. Modern Healthcare (subscription required) (2/28) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
  • Diagnostic CT and PET/CT cases available
    Meet PET/CT and Diagnostic CT training and credentialing recommendations. These cases have been designed so nuclear medicine physicians with no recent CT training can supervise and interpret CT images in conjunction with PET or SPECT. They also allow radiologists with no recent PET training to supervise and interpret PET images in conjunction with CT. Get started today. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
Mediocrity knows nothing higher than itself, but talent instantly recognizes genius."
--Sir Arthur Conan Doyle,
Scottish-born writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information